Skip to main content
Erschienen in: BMC Cardiovascular Disorders 1/2020

Open Access 01.12.2020 | Case report

Alternate recurrent coronary artery spasm and stress cardiomyopathy: a case report

verfasst von: Yunpeng Jin, Qiming Li, Xiaogang Guo

Erschienen in: BMC Cardiovascular Disorders | Ausgabe 1/2020

Abstract

Background

Coronary artery spasm (CAS) and stress cardiomyopathy (SC) have different characteristic clinical manifestations in the case of suspicious myocardial infarction with nonobstructive coronary arteries. Established recurrence rates of both conditions have been reported, however, alternate recurrent CAS and SC in the same individual have not been described.

Case presentation

A 59-year-old man suffered from atypical chest pain in the first episode, acute heart attack in the second and third episodes (totally 3 times over a period of approximately 5 years). During the first episode, he visited our hospital with mild paroxysmal chest pain without obvious inducement for approximately 2 years. He was underdiagnosed at that time without other obvious findings except the poor R wave progression in V1–3 leads revealed in electrocardiogram. At 4 months after the first episode, he suffered from a heart attack (the second episode) and was diagnosed with SC based on the coronary angiography (CAG) and left ventriculography findings of nonobstructive coronary arteries combined with a classic apical ballooning shape. At 31 months after the second episode, he suffered another heart attack (the third episode) and was diagnosed with CAS based on the CAG results of recoverable severe multivessel stenoses. During the episodes, partial reversible nature of apical hypokinesis was observed in echocardiogram. In retrospect, the patient suffered silent CAS in the first episode, SC in the second episode, and severe multivessel CAS in the third episode.

Conclusion

The unusual presentations observed in this case have not been reported. This case suggests that cardiologists should be aware of the possibility of alternate recurrent CAS and SC in the same individual. Provocative tests for spasm and cardiac magnetic resonance imaging might help gain more insights into this issue.
Begleitmaterial
Additional file 1. Left ventriculography during the second episode.
Additional file 5. Coronary angiography during the third episode.
Additional file 6. Coronary angiography during the third episode after the intracoronary injection of nitroglycerin.
Hinweise

Supplementary information

Supplementary information accompanies this paper at https://​doi.​org/​10.​1186/​s12872-020-01760-2.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
CAS
Coronary artery spasm
SC
Stress cardiomyopathy
MINOCA
Myocardial infarction with nonobstructive coronary arteries
CAG
Coronary angiography
ECG
Electrocardiogram
AMI
Acute myocardial infarction
cTnT
Cardiac troponin T
CK-MB
Creatine kinase-MB
LVEF
Left ventricular ejection fraction
BNP
Brain natriuretic peptide
HbA1c
Glycated hemoglobin A1c
CCBs
Calcium channel blockers
CMRI
Cardiac magnetic resonance imaging
DAPT
Dual antiplatelet therapy

Background

Coronary artery spasm (CAS) generally causes transient myocardial ischemia with the manifestations of paroxysmal chest pain and recoverable electrocardiogram (ECG) changes; however, it may also cause life-threatening heart events such as acute myocardial infarction (AMI), lethal arrhythmias, and even sudden death despite its transient nature, especially in the case of multivessel involvement [1].
A definite and timely diagnosis of CAS remains extremely challenging because provocation tests are rarely performed due to the concern regarding its safety [2], although such tests for CAS have been confirmed to be safe and have relevant prognostic implications [3]. Patients are diagnosed with CAS generally based on characteristic clinical manifestations, although atypical scenarios appear occasionally.
Stress cardiomyopathy (SC), also known as Takotsubo syndrome, apical ballooning syndrome, or broken heart syndrome, is a benign disorder characterized by a variety of transient abnormalities in the left ventricular wall motion. Despite its increasing awareness, underdiagnosed and misdiagnosed conditions remain common because of its deceptive clinical manifestations and heterogeneity of clinical findings [4].
CAS and SC have different characteristic clinical manifestations in the case of suspicious myocardial infarction with nonobstructive coronary arteries (MINOCA). Established recurrence rates of both CAS and SC have been reported, however, alternate recurrent CAS and SC in the same individual have not been described.
Herein, we describe a case of alternate recurrent CAS and SC in the same individual, which was observed for the first time.

Case presentation

A 59-year-old man suffered from atypical chest pain in the first episode and acute heart attack in the second and third episodes (totally 3 times over a period of approximately 5 years). He was a businessman of Han nationality. Past, personal, and family history had no distinct findings, except for a history of smoking one pack of cigarettes per day for 20 years. The timeline of the three episodes are shown in Table 1.
Table 1
Timeline of the three episodes
Date
Episode
Main symptoms
Main examination
Medication
2016-10-07
First
Mild paroxysmal chest pain without obvious inducement for approximately 2 years
On arrival
ECG revealed poor R wave progression and suspicious ST-segment elevation in V1–3 leads
Echocardiogram findings and cTnT and CK-MB levels were normal
Coronary computed tomography angiography showed mild coronary atherosclerotic lesions
He refused to take any medicine at that time
2017-02-15
Second
Chest pain aggravated 1 h ago after waking up (without physical or emotional triggers) at about 7:30 a.m
On arrival
ECG revealed ST-segment elevation in V2–6 leads
Emergency CAG was performed that showed no significant atherosclerotic lesions
Left ventriculography revealed apical hypokinesis with a classic apical ballooning shape
Echocardiogram showed severe apical hypokinesis, and LVEF was 52%
CK-MB and cTnT levels were elevated
Aspirin, clopidogrel, statins, angiotensin II type 1 receptor blockers, beta-adrenergic blockers, and insulin. (DAPT stopped after 1 year)
   
5 days later
ECG showed recovered ST-segment elevation in V2–6 leads, echocardiogram revealed no significant improvement
 
   
8 months later
Echocardiogram showed moderate apical hypokinesis, and LVEF was 55%
 
   
26 months later
ECG revealed no ST-segment elevation, echocardiogram showed mild apical hypokinesis, and LVEF was 68.7%
 
2019-10-04
Third
Severe chest pain occurred again 8 h ago when he was resting at about 2:39 a.m
On arrival
ECG revealed ST-segment elevation in II, III, avF, and V1–4 leads. Echocardiogram showed mild left ventricular wall motion reduction, severe apical hypokinesis, and LVEF was 55%
Emergency CAG revealed severe stenoses in the left anterior descending and posterior left ventricle arteries, which reversed after intracoronary injection of nitroglycerin
CK-MB and cTnT levels were normal
Calcium channel blockers, statins, and insulin
   
3 days later
ECG revealed recovered ST-segment elevation in II, III, avF, and V1–4 leads. Echocardiogram showed normal left ventricular wall motion and mild apical hypokinesis, and LVEF was 70.8%
He was insisted on medication and regular follow-up after discharge
  
No chest pain
Till date
 
No drug dose adjusted
ECG electrocardiogram, cTnT cardiac troponin T, CK-MB creatine kinase-MB, CAG coronary angiography, LVEF left ventricular ejection fraction, DAPT dual antiplatelet therapy

The first episode

He visited our hospital with mild paroxysmal chest pain without obvious inducement for approximately 2 years. The chest pain was located in the substernal area, characterized by a squeezing pattern and lasted minutes or hours. ECG revealed poor R wave progression and suspicious ST-segment elevation in V1–3 leads (Fig. 1), whereas echocardiogram findings and cardiac troponin T (cTnT) and creatine kinase-MB (CK-MB) levels were normal. Coronary computed tomography angiography showed mild coronary atherosclerotic lesions. He was diagnosed with diabetes and hypertension simultaneously, but he refused to take any medicine at that time.

The second episode

At 4 months after the first episode, he presented to the emergency room with chest pain that aggravated 1 h ago after waking up (without physical or emotional triggers) at about 7:30 a.m. On arrival, his vital signs and physical examination findings were normal. ECG revealed ST-segment elevation in V2–6 leads (Fig. 2). The chest pain was located in the substernal area, characterized by a squeezing pattern and relieved after approximately 30 min before coronary angiography (CAG) was performed. The InterTAK diagnostic score was 18 [5], and the prognostic score was 12 [6]. An emergency CAG was performed that showed no significant atherosclerotic lesions (Fig. 3a). Left ventriculography disclosed apical hypokinesis with a classic apical ballooning shape (Fig. 3b). Additional movie files show this in more detail [see Additional file 1]. Echocardiogram revealed severe apical hypokinesis, and the left ventricular ejection fraction (LVEF) was 52%. Additional image files show this in more detail [see Additional file 2]. Laboratory data showed cTnT levels of 0.021 and 0.796 ng/mL at the peak (relative index < 0.014 ng/mL) and CK-MB levels of 17.2 and 40.4 U/L at the peak (relative index < 24 U/L). His brain natriuretic peptide (BNP) level was 108.1 pg/ml (relative index < 100 pg/ml), low-density lipoprotein cholesterol (LDL-C) level was 1.36 mmol/L (normal range 0–3.36 mmol/L), fasting blood glucose level was 7.34 mmol/L (normal range 3.9–6.1 mmol/L), and glycated hemoglobin A1c (HbA1c) level was 11.2% (normal range 3.6–6.0%). Other examinations showed no remarkable findings. He was diagnosed with SC and treated with long-term medicines, including aspirin, clopidogrel, statins, angiotensin II type 1 receptor blockers, beta-adrenergic blockers, and insulin.
After 5 days, the ECG revealed recovered ST-segment elevation in V2–6 leads (Fig. 4), echocardiogram showed severe apical hypokinesis, and the LVEF was 51%. An additional image file shows this in more detail [see Additional file 3]. After 8 months, the echocardiogram revealed moderate apical hypokinesis, and the LVEF was 55%. After 26 months, no ST-segment elevation was detected on the ECG (Fig. 5), and the echocardiogram revealed mild apical hypokinesis, with the LVEF being 68.7%. Mild paroxysmal chest pain occurred rarely during the follow-up. He did not quit smoking despite our repeated recommendation.

The third episode

At 31 months after the second episode, he again visited our emergency room with severe chest pain (squeezing sensation in the substernal area) that occurred 8 h ago when he was resting at about 2:39 a.m. On arrival, his vital signs and physical examination were normal. ECG revealed ST-segment elevation in II, III, avF, and V1–4 leads (Fig. 6). Echocardiogram showed mild left ventricular wall motion reduction, server apical hypokinesis, and the LVEF was 55%. An additional image file shows this in more detail [see Additional file 4]. An emergency CAG revealed severe stenoses (Fig. 3c) in the left anterior descending and posterior left ventricle arteries, which reversed after intracoronary injection of nitroglycerin (Fig. 3d). Additional movie files show this in more detail [see Additional file 5, 6]. Then, the chest pain relieved. His N-terminal pro-BNP level was 266.4 ng/L (relative index < 125 ng/l), fasting blood glucose level was 8.4 mmol/L (normal range 3.9–6.1 mmol/L), and HbA1c level was 10.1% (normal range 3.6–6.0%). Other examinations showed no remarkable findings. He was diagnosed with CAS. An additional treatment with calcium channel blockers (CCBs) was initiated, and beta-adrenergic blockers were stopped.
After 3 days, the ECG revealed recovered ST-segment elevation in II, III, avF, and V1–4 leads (Fig. 7), the echocardiogram showed normal left ventricular wall motion and mild apical hypokinesis, and the LVEF was 70.8%. Additional image files show this in more detail [see Additional file 7]. He quit smoking after the second attack. He was insisted on medication and regular follow-up after discharge. No chest pain has occurred till date.

Discussion and conclusion

Aspect of diagnosis

This patient presented with suspicious MINOCA in the second episode, and according to the working diagnosis of MINOCA [7], SC and CAS are the most likely diagnosis.
SC was diagnosed initially according to the revised Mayo Clinic criteria at that time, although a definite diagnosis could not be established then because of the uncertain reversible nature of the condition. Partial reversible nature of apical hypokinesis was observed in the echocardiogram during the follow-up. Moreover, the InterTAK diagnostic score is low (only 18 points of 100 points), which have been published as a new recommended diagnostic criteria recently [8]. In other words, the diagnosis of SC during the second episode was still uncertain. However, contrast cardiac magnetic resonance imaging (CMRI) was not performed to detect edema (to confirm SC) at that time due to limited hospital resources.
As multivessel CAS was diagnosed definitely during the third episode, it could have occurred during the second episode as well. Retrospectively, the clinical manifestations are more consistent with the characteristics of CAS than with SC (chest pain occurred at rest in the early morning repeatedly without physical or emotional triggers). Moreover, CAS can diffusely involve the entire arteries and migrate from site to site, which may also cause severe apical hypokinesis with apical ballooning images [9]; multivessel spasm theory [10] also supports this possibility. However, the coronary images showed a wraparound left anterior descending branch, which contradicts this possibility. That it to say, CAS could not be the cause of the second episode. Unfortunately, we did not perform provocative tests, which are known as the key diagnostic criteria of CAS, during the second episode due to the insufficient evidence basis at that time. Recently, provocative tests for spasm have been confirmed to be safe and are recommended in the situation of rest angina without obstructive coronary artery disease [11].
Our understanding of both CAS and SC is still limited. CAS and SC share some predisposing factors and pathogenic mechanisms, such as emotional triggers and adrenergic hyperactivation, and some evidence suggests a potential pathogenic link between these two conditions [12]. In other words, CAS and SC may be two expressions of the same disease, or rather two separate entities with overlapping mechanisms. In the present case, we could not draw the conclusion definitely because of the important limitation that CMRI and provocative tests were not performed.
Another important limitation is that left ventriculography was not performed during the third episode, which could also have been of great help to assess the appearance of a classic apical ballooning shape. However, we believe that both CAS and SC exist in this case, which is because this explanation is the most reasonable for this case as we have discussed earlier.
Furthermore, it is interesting that during the first episode, the patient’s ECG revealed poor R wave progression in V1–3 leads despite normal echocardiogram and CAG findings, which may have resulted due to small areas of prior myocardial infarction with silent manifestation caused by CAS. In addition, the first episode might point to microvascular endothelial dysfunction, and this microvascular dysfunction could be a risk factor for both CAS and SC [12].
In summary, the patient suffered silent CAS in the first episode, SC in the second episode, and severe multivessel CAS in the third episode. Alternate recurrent CAS and SC in the same individual as observed in this case has not been reported till date.

Aspect of treatment

During the second episode, the patient was discharged on dual antiplatelet therapy (DAPT). However, according to the latest recommendation, in the absence of CAD and in patients with TS or CAS, DAPT increases the risk of bleeding without an obvious benefit in this population, and even the role of aspirin at low doses has discussed over the years [13].
Moreover, beta-adrenergic blockers known as a risk factor for CAS were prescribed according to the treatment principles of SC [14], which may have been the trigger of the third episode. Therefore, beta-adrenergic blockers should be cautiously used before severe multivessel CAS has been completely excluded despite the typical scenarios of SC.
To our best knowledge, the unusual presentations as observed in this case have not been reported in the literature. Cardiologists should be aware of the possibility of alternate recurrent CAS and SC in the same individual. Provocative tests for spasm and cardiac magnetic resonance imaging might help gain more insights into this issue.

Supplementary information

Supplementary information accompanies this paper at https://​doi.​org/​10.​1186/​s12872-020-01760-2.

Acknowledgements

Not applicable.
Ethical approval for the publication of this study was obtained from the Ethics Committee of The Fourth Affiliated Hospital of Zhejiang University School of Medicine. Informed consent was obtained from the patient included in the study.
Written informed consent was obtained from the patient for the publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.

Competing interests

The authors declare that they have no competing interests.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Anhänge

Supplementary information

Additional file 1. Left ventriculography during the second episode.
Additional file 5. Coronary angiography during the third episode.
Additional file 6. Coronary angiography during the third episode after the intracoronary injection of nitroglycerin.
Literatur
1.
Zurück zum Zitat Slavich M, Patel RS. Coronary artery spasm: current knowledge and residual uncertainties. Int J Cardiol Heart Vasc. 2016;23(10):47–53. Slavich M, Patel RS. Coronary artery spasm: current knowledge and residual uncertainties. Int J Cardiol Heart Vasc. 2016;23(10):47–53.
2.
Zurück zum Zitat Takagi Y, Yasuda S, Takahashi J, Tsunoda R, et al. Clinical implications of provocation tests for coronary artery spasm: safety, arrhythmic complications, and prognostic impact: multicentre registry study of the Japanese Coronary Spasm Association. Eur Heart J. 2013;34(4):258–67.CrossRef Takagi Y, Yasuda S, Takahashi J, Tsunoda R, et al. Clinical implications of provocation tests for coronary artery spasm: safety, arrhythmic complications, and prognostic impact: multicentre registry study of the Japanese Coronary Spasm Association. Eur Heart J. 2013;34(4):258–67.CrossRef
3.
Zurück zum Zitat Montone RA, Niccoli G, Fracassi F, Russo M, et al. Patients with acute myocardial infarction and non-obstructive coronary arteries: safety and prognostic relevance of invasive coronary provocative tests. Eur Heart J. 2018;39(2):91–8.PubMed Montone RA, Niccoli G, Fracassi F, Russo M, et al. Patients with acute myocardial infarction and non-obstructive coronary arteries: safety and prognostic relevance of invasive coronary provocative tests. Eur Heart J. 2018;39(2):91–8.PubMed
4.
Zurück zum Zitat Templin C, Ghadri JR, Diekmann J, Napp LC, et al. Clinical features and outcomes of Takotsubo (stress) cardiomyopathy. N Engl J Med. 2015;373(10):929–38.CrossRefPubMed Templin C, Ghadri JR, Diekmann J, Napp LC, et al. Clinical features and outcomes of Takotsubo (stress) cardiomyopathy. N Engl J Med. 2015;373(10):929–38.CrossRefPubMed
5.
Zurück zum Zitat Ghadri JR, Cammann VL, Jurisic S, Seifert B, et al. A novel clinical score (InterTAK Diagnostic Score) to differentiate takotsubo syndrome from acute coronary syndrome: results from the International Takotsubo Registry. Eur J Heart Fail. 2017;19(8):1036–42.CrossRefPubMed Ghadri JR, Cammann VL, Jurisic S, Seifert B, et al. A novel clinical score (InterTAK Diagnostic Score) to differentiate takotsubo syndrome from acute coronary syndrome: results from the International Takotsubo Registry. Eur J Heart Fail. 2017;19(8):1036–42.CrossRefPubMed
6.
Zurück zum Zitat Wischnewsky MB, Candreva A, Bacchi B, Cammann VL, et al. Prediction of short- and long-term mortality in Takotsubo syndrome: the InterTAK Prognostic Score. Eur J Heart Fail. 2019;21(11):1469–72.CrossRefPubMed Wischnewsky MB, Candreva A, Bacchi B, Cammann VL, et al. Prediction of short- and long-term mortality in Takotsubo syndrome: the InterTAK Prognostic Score. Eur J Heart Fail. 2019;21(11):1469–72.CrossRefPubMed
7.
Zurück zum Zitat Tamis-Holland JE, Jneid H, Reynolds HR, Agewall S, et al. Contemporary diagnosis and management of patients with myocardial infarction in the absence of obstructive coronary artery disease: a scientific statement from the American Heart Association. Circulation. 2019;139(18):e891–908.CrossRefPubMed Tamis-Holland JE, Jneid H, Reynolds HR, Agewall S, et al. Contemporary diagnosis and management of patients with myocardial infarction in the absence of obstructive coronary artery disease: a scientific statement from the American Heart Association. Circulation. 2019;139(18):e891–908.CrossRefPubMed
8.
Zurück zum Zitat Del-Buono MG, Potere N, Chiabrando JG, Bressi E, et al. Takotsubo syndrome: diagnostic work-up and clues into differential diagnosis. Curr Opin Cardiol. 2019;34(6):673–86.CrossRefPubMed Del-Buono MG, Potere N, Chiabrando JG, Bressi E, et al. Takotsubo syndrome: diagnostic work-up and clues into differential diagnosis. Curr Opin Cardiol. 2019;34(6):673–86.CrossRefPubMed
9.
Zurück zum Zitat Yasue H, Mizuno Y, Harada E. Coronary artery spasm—clinical features pathogenesis and treatment. Proc Jpn Acad Ser B Phys Biol Sci. 2019;95(2):53–66.CrossRefPubMedPubMedCentral Yasue H, Mizuno Y, Harada E. Coronary artery spasm—clinical features pathogenesis and treatment. Proc Jpn Acad Ser B Phys Biol Sci. 2019;95(2):53–66.CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Angelini P. Transient left ventricular apical ballooning: a unifying pathophysiologic theory at the edge of Prinzmetal angina. Catheter Cardiovasc Interv. 2008;71(3):342–52.CrossRefPubMed Angelini P. Transient left ventricular apical ballooning: a unifying pathophysiologic theory at the edge of Prinzmetal angina. Catheter Cardiovasc Interv. 2008;71(3):342–52.CrossRefPubMed
11.
Zurück zum Zitat Bil J, Pietraszek N, Pawlowski T, Gil RJ. Advances in mechanisms and treatment options of MINOCA caused by vasospasm or microcirculation dysfunction. Curr Pharm Des. 2018;24(4):517–31.CrossRefPubMed Bil J, Pietraszek N, Pawlowski T, Gil RJ. Advances in mechanisms and treatment options of MINOCA caused by vasospasm or microcirculation dysfunction. Curr Pharm Des. 2018;24(4):517–31.CrossRefPubMed
14.
Zurück zum Zitat Medinadechazal H, Del Buono MG, Keyser-Marcus L, et al. Stress cardiomyopathy diagnosis and treatment: JACC state-of-the-art review. J Am Coll Cardiol. 2018;72(16):1955–71.CrossRef Medinadechazal H, Del Buono MG, Keyser-Marcus L, et al. Stress cardiomyopathy diagnosis and treatment: JACC state-of-the-art review. J Am Coll Cardiol. 2018;72(16):1955–71.CrossRef
Metadaten
Titel
Alternate recurrent coronary artery spasm and stress cardiomyopathy: a case report
verfasst von
Yunpeng Jin
Qiming Li
Xiaogang Guo
Publikationsdatum
01.12.2020
Verlag
BioMed Central
Erschienen in
BMC Cardiovascular Disorders / Ausgabe 1/2020
Elektronische ISSN: 1471-2261
DOI
https://doi.org/10.1186/s12872-020-01760-2

Weitere Artikel der Ausgabe 1/2020

BMC Cardiovascular Disorders 1/2020 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.